Big Pharma Upheaval Coming -- This Stock Is Poised to Skyrocket, Anyway

Big pharmaceutical companies haven't had to worry about negotiating drug prices with the U.S. government as they do in Europe and other parts of the world. That's almost certainly about to change.

The U.S. Senate passed the Inflation Reduction Act of 2022 last week. There's a lot in this legislation, including a provision that will allow Medicare to directly negotiate the prices of the costliest drugs. The U.S. House of Representatives is expected to vote in favor of the bill later this week. President Joe Biden has already stated that he's ready to sign it into law.

A major upheaval for big pharma is probably coming soon. But there's one stock that's poised to skyrocket, anyway.

Continue reading

Source Fool.com